jRCT2031210584已完成不适用
SJP-0130 Phase 2 -Placebo Controlled Parallel Group Study in Primary Open Angle Glaucoma or Ocular Hypertention patients-
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 75
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Double Blind
入排标准
- 年龄范围
- 20age old over 至 75age old not（—）
- 性别
- All
入选标准
- •Aged 20 years or older and less than 75 years at the time of the informed consent
- •Male or non-childbearing potential female patients
- •Have been diagnosed with primary open angle glaucoma or ocular hypertension
- •Meet the other protocol-specified inclusion criteria
排除标准
- •Received treatment of glaucoma other than eye drops in eye
- •Received surgery or laser therapy in eye
- •Have ophthalmic disease other than primary open angle glaucoma or ocular hypertention
- •Have known history of hypersensitivity or serious adverse reaction to any of the study drug ingredients
- •Have advanced visual field disorder
- •Have eye abnomalitites that interfere with accurate measurement of ocular pressure
- •Have judged that it is inappropriate to participate in this study by investigator
- •Meet the other protocol-specified exclusion criteria
结局指标
主要结局
-
Efficacy and safety
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Placebo Controlled, Parallel-Group Study of SJP-0132 in Patients with Dry Eye DiseaseDry Eye DiseasejRCT2031220497Senju Pharmaceutical Co., Ltd.498
已完成
不适用
Placebo Controlled, parallel-Group Study of SJP-0154 in Patients with Dry Eye DiseaseDry Eye DiseasejRCT2031240009Senju Pharmaceutical Co., Ltd.330
招募中
不适用
Placebo Controlled, Parallel-Group Study of SJP-0049 in Patients with Allergic ConjunctivitisAllergic ConjunctivitisjRCT2031250103Senju Pharmaceutical Co., Ltd.112
进行中（未招募）
不适用
Placebo-Controlled, Parallel-Group Study of SJP-0008 in Participants with Central Retinal Artery OcclusionCentral Retinal Artery OcclusionjRCT2011230042Senju Pharmaceutical Co., Ltd.60
已完成
不适用
Randomized, placebo-controlled Phase I study of SJP-0008 in healthy adult volunteers (single and repeated dose study)Healthy adultsJPRN-UMIN000019104Senju Pharmaceutical co.,ltd.90